Ovarian function: A theory of relativity

Human Reproduction

Volumn 24, Issue 1, 2009, Pages 17-19

  Weghofer, Andrea ^a,b   Gleicher, Norbert ^b,c  

^a UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^b Foundation for Reproductive Medicine   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

FSH; Hormonal ratios; LH; Ovarian function; Physiological equilibrium

Indexed keywords

FOLLITROPIN; LUTEINIZING HORMONE;

EMBRYOLOGY; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONAL REGULATION; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; HYPOTHESIS; LUTEINIZING HORMONE BLOOD LEVEL; NOTE; OOCYTE DEVELOPMENT; OVARY FUNCTION; REPRODUCTION; SCIENTIFIC LITERATURE; STEROIDOGENESIS;

EID: 57749195564     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/den363     Document Type: Note

References (25)

1. Babbur V, Lees CC, Goodburn SF, Morris N, Breeze AC, Hackett GA. Prospective audit of a one-centre combined nuchal translucency and triple test programme for the detection of trisomy 21. Prenat Diagn 2005;25:465-469.
2. Bjercke S, Fedorcsak P, Abyholm T, Storeng R, Ertzeid G, Oldereid N, Omland A, Tanbo T. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression. Hum Reprod 2005;20:2441-2447.
3. De Placido G, Alviggi C, Perino A, Strina I, Lisi F, Fasolino A, De Palo R, Ranieri A, Colacurci N, Mollo A. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum Reprod 2005;20:390-396.
4. Falck B. Site of production of oestrogen in the ovary of the rat. Nature 1959;184(Suppl 14):1082.
5. Frattarelli JL, Peterson EH. Effect of androgen levels on in vitro fertilization cycles. Fertil Steril 2004;81:1713-1714.
6. Gleicher N, Karande V. Generic human menopausal gonadotropin (hMG) in place of more costly follicle-stimulating hormone (FSH) for routine ovulation induction. J Assist Reprod Genet 2000;17:489-495.
7. Jerne NK. Idiotypic networks and other preconceived ideas. Immunol Rev 1984;79:5-24.
8. Kol S, Homburg R. Change, change, change: hormonal actions depend on changes in blood levels. Hum Reprod 2008;23:1004-1006.
9. Liu KE, Greenblatt EM. Elevated day 3 follicle-stimulating hormone/ luteinizing hormone ratio ≥2 is associated with higher rates of cancellation in in vitro fertilization-embryo transfer cycles. Fertil Steril 2008;90:297-301.
10. Malhi PS, Adams GP, Singh J. Bovine model for the study of reproductive aging in women: follicular, luteal, and endocrine characteristics. Biol Reprod 2005;73:45-53.
11. Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L. An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril 1996;65:588- 593.
12. Palermo R. Differential actions of FSH and LH during folliculogenesis. Reprod Biomed Online 2007;15:326-337.
13. Pehlivan T, Rubio C, Rodrigo L, Romero J, Remohi J, Simon C, Pellicer A. Impact of preimplantation genetic diagnosis on IVF outcome in implantation failure patients. Reprod Biomed Online 2003;6:232-237.
14. Penarrubia J, Fabregues F, Creus M, Manau D, Casamitjana R, Guimera M, Carmona F, Vanrell JA, Balasch J. LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH. Hum Reprod 2003;18:2689-2697.
15. Ranieri DM, Quinn F, Makhlouf A, Khadum I, Ghutmi W, McGarrigle H, Davies M, Serhal P. Simultaneous evaluation of basal follicle-stimulating hormone and 17 beta-estradiol response to gonadotropin-releasing hormone analogue stimulation: an improved predictor of ovarian reserve. Fertil Steril 1998;70:227-233.
16. Rekha P, Mowat L, Jamieson ME, Yates RW, Fleming R. Effect of profound suppression of luteinizing hormone during treatment with gonadotrophin-releasing hormone analogue and purified follicle stimulating hormone upon development of cryopreserved embryos. Hum Reprod 1998;13:696-698.
17. Shrim A, Elizur SE, Seidman DS, Rabinovici J, Wiser A, Dor J. Elevated day 3 FSH/LH ratio due to low LH concentrations predicts reduced ovarian response. Reprod Biomed Online 2006;12:418-422.
18. Speroff LGR, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 6th edn. Lippincott: Williams and Wilkins, 1999.
19. Stein I, Leventhal M. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935;29:181.
20. Toner JP. Modest follicle-stimulating hormone elevations in younger women: warn but don't disqualify. Fertil Steril 2004;81:1493-1495, discussion 1496-1497.
21. van Rooij IA, Bancsi LF, Broekmans FJ, Looman CW, Habbema JD, te Velde ER. Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril 2003; 79:482-488.
22. Weghofer A, Feichtinger W. The forgotten variable: impact of luteinizing hormone on the prediction of ovarian reserve. Fertil Steril 2006; 85:259-261.
23. Weghofer A, Margreiter M, Fauster Y, Schaetz T, Brandstetter A, Boehm D, Feichtinger W. Age-specific FSH levels as a tool for appropriate patient counselling in assisted reproduction. Hum Reprod 2005;20:2448- 2452.
24. Yong PY, Baird DT, Thong KJ, McNeilly AS, Anderson RA. Prospective analysis of the relationships between the ovarian follicle cohort and basal FSH concentration, the inhibin response to exogenous FSH and ovarian follicle number at different stages of the normal menstrual cycle and after pituitary down-regulation. Hum Reprod 2003;18:35-44.
25. Younis JS, Matilsky M, Radin O, Ben-Ami M. Increased progesterone/ estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertil Steril 2001; 76:294-299.